{"id":"W2888908066","doi":"10.1007/s12325-018-0772-3","title":"Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United States","year":2018,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Novartis Pharmaceuticals Corporation","keywords":"Nilotinib; Dasatinib; Medicine; Myeloid leukemia; Internal medicine; Cohort; Retrospective cohort study; Oncology; Imatinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005876816,0.0003331781,0.0006126867,0.0005802528,0.0001617744,0.00001852534,0.0002888597,0.00009432067,0.0001238923],"category_scores_gemma":[0.0001652504,0.0002208758,0.00007234103,0.002538955,0.0003541606,0.0003097487,0.00005561101,0.0005573303,0.000008417314],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004620247,"about_ca_system_score_gemma":0.0006619082,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02046022,"about_ca_topic_score_gemma":0.1115765,"domain_scores_codex":[0.9971637,0.0004686613,0.0007817282,0.0005454564,0.0005286693,0.0005117912],"domain_scores_gemma":[0.9979759,0.0005098546,0.000398234,0.0007402174,0.0002957804,0.00007998912],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008619446,0.0008198004,0.9603539,0.00005772201,0.00009462157,0.0000206703,0.02037199,0.0003184974,0.0000306648,0.0000472127,0.00003525514,0.01698774],"study_design_scores_gemma":[0.01211505,0.008882513,0.9705064,0.0005412444,0.00002857011,0.000004160051,0.004707901,0.000445892,0.0002129314,0.0004645122,0.001881614,0.0002092693],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949258,0.0006154714,0.000006749994,0.0002165209,0.0002644289,0.002765342,0.00002073599,0.00007273891,0.001112232],"genre_scores_gemma":[0.9900885,0.008670428,0.0001153332,0.0001855525,0.0002738163,0.0003340575,0.00009571587,0.00005513893,0.0001814846],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09111627,"threshold_uncertainty_score":0.9992008,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02334276139145518,"score_gpt":0.3478041825949271,"score_spread":0.3244614212034719,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}